Comparing the Biology of Young versus Old Age Estrogen-Receptor-Positive Breast Cancer through Gene and Protein Expression Analyses
Authors:
- Alaa SiddigAlaa Siddig
- Wan Faiziah Wan Abdul RahmanWRWan Faiziah Wan Abdul Rahman
- Siti Norasikin Mohd NafiSNSiti Norasikin Mohd Nafi
- Sarina SulongSSSarina Sulong
- Maya Mazuwin YahyaMYMaya Mazuwin Yahya
- Tengku Ahmad Damitri Al-Astani Tengku DinTDTengku Ahmad Damitri Al-Astani Tengku Din
- Rozaimi RazaliRRRozaimi Razali
- Kamarul Imran MusaKamarul Imran Musa
Open Access
- 12 January 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 200
Abstract
Background: Breast cancer developed at a young age (≤45 years) is hypothesized to have unique biology; however, findings in this field are controversial. Methods: We compared the whole transcriptomic profile of young vs. old-age breast cancer using DNA microarray. RNA was extracted from 13 fresh estrogen receptor (ER)-positive primary breast cancer tissues of untreated patients (7 = young age ≤45 years and 6 = old age ≥55 years). In silico validation for the differentially expressed genes (DEGs) by young-age patients was conducted using The Cancer Genome Atlas (TCGA) database. Next, we analyzed the protein expression encoded by two of the significantly down-regulated genes by young-age patients, Glycine N-acyltransferase-like 1 (GLYATL-1) and Ran-binding protein 3 like (RANBP3L), using immunohistochemical analysis in an independent cohort of 56 and 74 ER-positive pre-therapeutic primary breast cancer tissues, respectively. Results: 12 genes were significantly differentially expressed by young-age breast cancers (fold change >2 or p-value < 0.05). TCGA data confirmed the differential expression of six genes. Protein expression analysis of GLYATL-1 and RANBP3L did not show heterogeneous expression between young and old-age breast cancer tissues. Loss of expression of GLYATL-1 was significantly (p-value 0.005) associated with positive lymph node status. Higher expression of RANBP3L was significantly associated with breast cancers with lower histopathological grades (p-value 0.038). Conclusions: At the transcriptomic level, breast cancer developed in young and old age patients seems homogenous. The variation in the transcriptomic profiles can be attributed to the other clinicopathological characteristics rather than the age of the patient.Keywords
Funding Information
- Ministry of Higher Education, Malaysia (FRGS/1/2019/SKK08/USM/02/15, 203.PPSP.6171249)
This publication has 51 references indexed in Scilit:
- Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression ProfilingClinical Cancer Research, 2012
- Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast CancerJournal of Clinical Oncology, 2011
- Macrophage-elicited loss of estrogen receptor-α in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locusOncogene, 2011
- Breast Carcinomas Arising at a Young Age: Unique Biology or a Surrogate for Aggressive Intrinsic Subtypes?Journal of Clinical Oncology, 2011
- The Impact of Age on Outcome in Early-Stage Breast CancerSeminars in Radiation Oncology, 2011
- Breast cancer in young womenBreast Cancer Research, 2010
- Correlations between RNA and protein expression profiles in 23 human cell linesBMC Genomics, 2009
- Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery firstRadiotherapy and Oncology, 2007
- Saturation and Quantization Reduction in Microarray Experiments using Two Scans at Different SensitivitiesStatistical Applications in Genetics and Molecular Biology, 2004
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003